Type-II diabetes and pancreatic cancer: A meta-analysis of 36 studies

R. Huxley, A. Ansary-Moghaddam, A. Berrington De González, F. Barzi, M. Woodward

Research output: Contribution to journalArticle

Abstract

Pancreatic cancer is the eighth major form of cancer-related death worldwide, causing 227 000 deaths annually. Type-II diabetes is widely considered to be associated with pancreatic cancer, but whether this represents a causal or consequential association is unclear. We conducted a meta-analysis to examine this association. A computer-based literature search from 1966 to 2005 yielded 17 case-control and 19 cohort or nested case-control studies with information on 9220 individuals with pancreatic cancer. The age and sex-adjusted odds ratio (OR) for pancreatic cancer associated with type-II diabetes was obtained from each study. The combined summary odds ratio was 1.82 (95% confidence interval (95% CI) 1.66-1.89), with evidence of heterogeneity across the studies (P = 0.002 for case-control and P = 0.05 for cohort studies) that was explained, in part, by higher risks being reported by smaller studies and studies that reported before 2000. Individuals in whom diabetes had only recently been diagnosed (

Original languageEnglish (US)
Pages (from-to)2076-2083
Number of pages8
JournalBritish Journal of Cancer
Volume92
Issue number11
DOIs
StatePublished - Jun 6 2005
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Type 2 Diabetes Mellitus
Meta-Analysis
Odds Ratio
Case-Control Studies
Cohort Studies
Confidence Intervals
Neoplasms

Keywords

  • Meta-analysis
  • Pancreatic cancer
  • Type-II diabetes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Huxley, R., Ansary-Moghaddam, A., Berrington De González, A., Barzi, F., & Woodward, M. (2005). Type-II diabetes and pancreatic cancer: A meta-analysis of 36 studies. British Journal of Cancer, 92(11), 2076-2083. https://doi.org/10.1038/sj.bjc.6602619

Type-II diabetes and pancreatic cancer : A meta-analysis of 36 studies. / Huxley, R.; Ansary-Moghaddam, A.; Berrington De González, A.; Barzi, F.; Woodward, M.

In: British Journal of Cancer, Vol. 92, No. 11, 06.06.2005, p. 2076-2083.

Research output: Contribution to journalArticle

Huxley, R, Ansary-Moghaddam, A, Berrington De González, A, Barzi, F & Woodward, M 2005, 'Type-II diabetes and pancreatic cancer: A meta-analysis of 36 studies', British Journal of Cancer, vol. 92, no. 11, pp. 2076-2083. https://doi.org/10.1038/sj.bjc.6602619
Huxley R, Ansary-Moghaddam A, Berrington De González A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: A meta-analysis of 36 studies. British Journal of Cancer. 2005 Jun 6;92(11):2076-2083. https://doi.org/10.1038/sj.bjc.6602619
Huxley, R. ; Ansary-Moghaddam, A. ; Berrington De González, A. ; Barzi, F. ; Woodward, M. / Type-II diabetes and pancreatic cancer : A meta-analysis of 36 studies. In: British Journal of Cancer. 2005 ; Vol. 92, No. 11. pp. 2076-2083.
@article{27cf4803bfa74fbc8f2f69ab30381a96,
title = "Type-II diabetes and pancreatic cancer: A meta-analysis of 36 studies",
abstract = "Pancreatic cancer is the eighth major form of cancer-related death worldwide, causing 227 000 deaths annually. Type-II diabetes is widely considered to be associated with pancreatic cancer, but whether this represents a causal or consequential association is unclear. We conducted a meta-analysis to examine this association. A computer-based literature search from 1966 to 2005 yielded 17 case-control and 19 cohort or nested case-control studies with information on 9220 individuals with pancreatic cancer. The age and sex-adjusted odds ratio (OR) for pancreatic cancer associated with type-II diabetes was obtained from each study. The combined summary odds ratio was 1.82 (95{\%} confidence interval (95{\%} CI) 1.66-1.89), with evidence of heterogeneity across the studies (P = 0.002 for case-control and P = 0.05 for cohort studies) that was explained, in part, by higher risks being reported by smaller studies and studies that reported before 2000. Individuals in whom diabetes had only recently been diagnosed (",
keywords = "Meta-analysis, Pancreatic cancer, Type-II diabetes",
author = "R. Huxley and A. Ansary-Moghaddam and {Berrington De Gonz{\'a}lez}, A. and F. Barzi and M. Woodward",
year = "2005",
month = "6",
day = "6",
doi = "10.1038/sj.bjc.6602619",
language = "English (US)",
volume = "92",
pages = "2076--2083",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Type-II diabetes and pancreatic cancer

T2 - A meta-analysis of 36 studies

AU - Huxley, R.

AU - Ansary-Moghaddam, A.

AU - Berrington De González, A.

AU - Barzi, F.

AU - Woodward, M.

PY - 2005/6/6

Y1 - 2005/6/6

N2 - Pancreatic cancer is the eighth major form of cancer-related death worldwide, causing 227 000 deaths annually. Type-II diabetes is widely considered to be associated with pancreatic cancer, but whether this represents a causal or consequential association is unclear. We conducted a meta-analysis to examine this association. A computer-based literature search from 1966 to 2005 yielded 17 case-control and 19 cohort or nested case-control studies with information on 9220 individuals with pancreatic cancer. The age and sex-adjusted odds ratio (OR) for pancreatic cancer associated with type-II diabetes was obtained from each study. The combined summary odds ratio was 1.82 (95% confidence interval (95% CI) 1.66-1.89), with evidence of heterogeneity across the studies (P = 0.002 for case-control and P = 0.05 for cohort studies) that was explained, in part, by higher risks being reported by smaller studies and studies that reported before 2000. Individuals in whom diabetes had only recently been diagnosed (

AB - Pancreatic cancer is the eighth major form of cancer-related death worldwide, causing 227 000 deaths annually. Type-II diabetes is widely considered to be associated with pancreatic cancer, but whether this represents a causal or consequential association is unclear. We conducted a meta-analysis to examine this association. A computer-based literature search from 1966 to 2005 yielded 17 case-control and 19 cohort or nested case-control studies with information on 9220 individuals with pancreatic cancer. The age and sex-adjusted odds ratio (OR) for pancreatic cancer associated with type-II diabetes was obtained from each study. The combined summary odds ratio was 1.82 (95% confidence interval (95% CI) 1.66-1.89), with evidence of heterogeneity across the studies (P = 0.002 for case-control and P = 0.05 for cohort studies) that was explained, in part, by higher risks being reported by smaller studies and studies that reported before 2000. Individuals in whom diabetes had only recently been diagnosed (

KW - Meta-analysis

KW - Pancreatic cancer

KW - Type-II diabetes

UR - http://www.scopus.com/inward/record.url?scp=21244485747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21244485747&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6602619

DO - 10.1038/sj.bjc.6602619

M3 - Article

C2 - 15886696

AN - SCOPUS:21244485747

VL - 92

SP - 2076

EP - 2083

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 11

ER -